{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=control+2&page=33", "query": { "intervention": "control 2", "page": 33 }, "page_size": 10 }, "pagination": { "page": 33, "page_size": 10, "total_count": 22175, "total_pages": 2218, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=control+2&page=34&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=control+2&page=32&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-27T12:51:11.080Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04775524", "title": "AWARENESS Trial (AWARENESS) of Storytelling Through Music in Healthcare Workers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Stress", "Post Traumatic Stress Disorder", "Work Related Stress" ], "interventions": [ { "name": "Storytelling Through Music (STM)", "type": "BEHAVIORAL" }, { "name": "Wait List / Storytelling Through Music-Hybrid", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2021-03-01", "completion_date": "2024-08-31", "has_results": false, "last_update_posted_date": "2024-11-19", "last_synced_at": "2026-10-27T12:51:11.080Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04775524" }, { "nct_id": "NCT01048359", "title": "Multidisciplinary Approach to Reduce Injury and Substance Abuse", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Drug Abuse" ], "interventions": [ { "name": "Brief advice", "type": "BEHAVIORAL" }, { "name": "Brief Intervention plus Booster", "type": "BEHAVIORAL" }, { "name": "Brief Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Texas at Austin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 417, "start_date": "2010-01", "completion_date": "2015-06", "has_results": false, "last_update_posted_date": "2015-11-25", "last_synced_at": "2026-10-27T12:51:11.080Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01048359" }, { "nct_id": "NCT01416259", "title": "A Phase I Study of the Effects of APF530 Exposure, Granisetron and Moxifloxacin", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Healthy" ], "interventions": [ { "name": "Withdraw treatment", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Heron Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 56, "start_date": "2011-07", "completion_date": "2011-10", "has_results": false, "last_update_posted_date": "2026-02-12", "last_synced_at": "2026-10-27T12:51:11.080Z", "location_count": 1, "location_summary": "West Bend, Wisconsin", "locations": [ { "city": "West Bend", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01416259" }, { "nct_id": "NCT04082780", "title": "Rifamycin in Minimal Hepatic Encephalopathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hepatic Encephalopathy", "Cirrhosis, Liver" ], "interventions": [ { "name": "Rifamycin SV MMX", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Hunter Holmes Mcguire Veteran Affairs Medical Center", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 30, "start_date": "2019-09-01", "completion_date": "2023-04-28", "has_results": false, "last_update_posted_date": "2023-09-21", "last_synced_at": "2026-10-27T12:51:11.080Z", "location_count": 1, "location_summary": "Richmond, Virginia", "locations": [ { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04082780" }, { "nct_id": "NCT00487825", "title": "Safety and Efficacy of Intravenous ACZ885 and Oral Methotrexate Therapy in Patients With Early Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Canakinumab (investigational)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Methotrexate (MTX)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 78, "start_date": "2007-03", "completion_date": "2008-12", "has_results": true, "last_update_posted_date": "2012-08-01", "last_synced_at": "2026-10-27T12:51:11.080Z", "location_count": 17, "location_summary": "Huntsville, Alabama • Tuscaloosa, Alabama • Paradise Valley, Arizona + 14 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Paradise Valley", "state": "Arizona" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "South Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00487825" }, { "nct_id": "NCT01168791", "title": "Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Soft Tissue Sarcoma" ], "interventions": [ { "name": "Palifosfamide-Tris", "type": "DRUG" }, { "name": "doxorubicin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alaunos Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 447, "start_date": "2010-08-16", "completion_date": "2013-03-13", "has_results": false, "last_update_posted_date": "2026-10-06", "last_synced_at": "2026-10-27T12:51:11.080Z", "location_count": 73, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 65 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01168791" }, { "nct_id": "NCT05981391", "title": "Neurobiological Similarities of Tinnitus and PTSD", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Posttraumatic Stress Disorder", "Tinnitus" ], "interventions": [ { "name": "resting-state functional MRI", "type": "DIAGNOSTIC_TEST" }, { "name": "Clinician Administered PTSD Scale for the DSM-5 (CAPS-5)", "type": "DIAGNOSTIC_TEST" }, { "name": "Tympanometry", "type": "DIAGNOSTIC_TEST" }, { "name": "Tinnitus Assessment", "type": "DIAGNOSTIC_TEST" }, { "name": "Otoscopy", "type": "DIAGNOSTIC_TEST" }, { "name": "Pure tone air and bone-conduction", "type": "DIAGNOSTIC_TEST" }, { "name": "Speech testing", "type": "DIAGNOSTIC_TEST" }, { "name": "Loudness Discomfort", "type": "DIAGNOSTIC_TEST" }, { "name": "Quick Speech in Noise Test", "type": "DIAGNOSTIC_TEST" }, { "name": "Distortion-Product Otoacoustic Emissions (DPOAE)", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "The University of Texas Health Science Center at San Antonio", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 64, "start_date": "2021-02-04", "completion_date": "2024-11-01", "has_results": true, "last_update_posted_date": "2025-07-08", "last_synced_at": "2026-10-27T12:51:11.080Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05981391" }, { "nct_id": "NCT07011420", "title": "Effects of Myoelectric Channel Count and Targeting for Upper Limb Prosthetic Control", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Amputation", "Amputation, Traumatic", "Amputation, Congenital", "Prosthesis User", "Upper Limb Amputation Below Elbow (Injury)", "Amputation; Traumatic, Arm: Forearm, Between Elbow and Wrist" ], "interventions": [ { "name": "Experimental socket with 4 untargeted channels active", "type": "DEVICE" }, { "name": "Experimental socket with 8 untargeted channels active", "type": "DEVICE" }, { "name": "Experimental socket with up to 16 untargeted channels active", "type": "DEVICE" }, { "name": "Experimental socket with 8 targeted channels active", "type": "DEVICE" }, { "name": "Coapt EMG Cuff", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Liberating Technologies, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 32, "start_date": "2025-10", "completion_date": "2026-06", "has_results": false, "last_update_posted_date": "2025-09-03", "last_synced_at": "2026-10-27T12:51:11.080Z", "location_count": 2, "location_summary": "Chicago, Illinois • Holliston, Massachusetts", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Holliston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07011420" }, { "nct_id": "NCT04112160", "title": "Prospective Randomized Controlled Trial for Pain Relief After Office Ureteral Stent Removal", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pain", "Urinary Stone", "Urinary Calculi" ], "interventions": [ { "name": "Ketorolac", "type": "DRUG" }, { "name": "normal saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "79 Years", "sex": "ALL", "summary": "18 Years to 79 Years" }, "enrollment_count": 125, "start_date": "2018-06-28", "completion_date": "2019-08-30", "has_results": true, "last_update_posted_date": "2024-01-10", "last_synced_at": "2026-10-27T12:51:11.080Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04112160" }, { "nct_id": "NCT03024060", "title": "Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Actinic Keratosis" ], "interventions": [ { "name": "ALA", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" }, { "name": "IBL 20 mW", "type": "DEVICE" }, { "name": "IBL 10 mW", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "DUSA Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2017-03", "completion_date": "2018-01", "has_results": false, "last_update_posted_date": "2017-11-07", "last_synced_at": "2026-10-27T12:51:11.080Z", "location_count": 7, "location_summary": "San Diego, California • Arlington Heights, Illinois • Carmel, Indiana + 4 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Arlington Heights", "state": "Illinois" }, { "city": "Carmel", "state": "Indiana" }, { "city": "Plainfield", "state": "Indiana" }, { "city": "Fridley", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03024060" } ] }